Vitamin D: More may not be better
In recent years, healthy people have been bombarded by stories in the media and on health websites warning about the dangers of too-low vitamin D levels, and urging high doses of supplements to protect against everything ...
Health
May 01, 2013 |
3 / 5 (4) |
3
Screening breast ultrasound detects cancers missed on mammography in women with dense breasts
Screening breast ultrasound performed after mammography on women with greater than 50% breast density detects an additional 3.4 cancers or high risk lesions per one thousand woman screened, a detection rate just under that ...
Cancer
Apr 18, 2013 |
not rated yet |
0
Take a kidney transplant now or wait for a better one? Researchers create 'decision' tool
Johns Hopkins scientists have created a free, Web-based tool to help patients decide whether it's best to accept an immediately available, but less-than-ideal deceased donor kidney for transplant, or wait for a healthier ...
Other
Apr 09, 2013 |
not rated yet |
0
Alcohol consumption has no impact on breast cancer survival
Although previous research has linked alcohol consumption to an increased risk of developing breast cancer, a new study has found that drinking before and after diagnosis does not impact survival from the disease. In fact, ...
Cancer
Apr 08, 2013 |
not rated yet |
0
No overall survival benefit tied to bilateral oophorectomy
(HealthDay)—At no age is there an overall survival benefit associated with bilateral oophorectomy compared with ovarian conservation at the time of hysterectomy for benign disease, according to a study ...
Obstetrics & gynaecology
Mar 25, 2013 |
not rated yet |
0
Surgery is superior to radiotherapy in men with localized PCa, Swedish study says
Surgery offers better survival benefit for men with localised prostate cancer, according to a large observational study, conducted by a group of researchers in Sweden and the Netherlands.
Cancer
Mar 15, 2013 |
not rated yet |
0
Surgery and radiation improve survival for metastatic gastric cancer patients, study shows
Researchers at Moffitt Cancer Center studied patients with metastatic gastric cancer and found that those who have both surgery and radiation have better survival than those who receive one or no form of treatment.
Cancer
Feb 27, 2013 |
not rated yet |
0
Peptide found to induce autophagy resulting in defense against diseases
(Medical Xpress)—A multi-disciplined team of researchers from the United States and The Netherlands has found that introducing a certain type of peptide into mice cells induces autophagy, which in turn helps in fighting ...
Medical research
Jan 31, 2013 |
5 / 5 (3) |
0
|
New marker of drug response may speed pace of lung cancer prevention trials
Testing medicines to prevent lung cancer requires treating many thousands of high-risk individuals and then waiting 5, 10 or 15 years to discover which of them develop cancer and which, if any, experience survival benefit ...
Cancer
Jan 08, 2013 |
not rated yet |
0
Olympians live longer than general population... But cyclists no survival advantage over golfers
Olympic medallists live longer than the general population, regardless of country of origin, medal won, or type of sport played, finds a study in the Christmas issue published on BMJ today.
Health
Dec 13, 2012 |
4.3 / 5 (3) |
5
|
Experimental graft-vs.-host disease treatment equivalent to standard care in Phase 3 trial
An experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3 trial at the American Society of ...
Cancer
Dec 10, 2012 |
not rated yet |
0
Study compares standard against newer treatment in women whose breast cancer has spread
Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, ...
Cancer
Dec 07, 2012 |
not rated yet |
0
Study says VeriStrat predicts response but not survival benefit from erlotinib
A study, published in the November 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed the plasma test VeriStrat can predict response but not survival benefi ...
Cancer
Oct 15, 2012 |
not rated yet |
0
Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer
Treatment with the drug sorafenib as a third or fourth line therapy does not result in improved overall survival among patients with advanced non-small cell lung cancer (NSCLC), according to findings released at the ESMO ...
Cancer
Sep 29, 2012 |
not rated yet |
0
Phase 3 trial confirms abiraterone acetate efficacy for patients with advanced prostate cancer
Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga) offers a significant survival benefit to patients with castration-resistant prostate cancer ...
Cancer
Sep 17, 2012 |
not rated yet |
0
